Scale |
AM (pre-dose) |
AM (post-dose) |
PM (pre-dose) |
PM (post-dose) |
** ARCI-A
Plc/Plc1
Plc/SYN115 |
1 (1-2)
2 (1-4)
|
1 (0-2)
2 (1-4)
|
1 (0-1)
2 (1-4)
|
1 (0-1)
3 (2-5)
|
ARCI-PCAG
Plc/Plc1
Plc/SYN115 |
4 (4-7)
4 (1-4)
|
7 (4.8-8)
4 (1-4)
|
5.03 (4-8)
4 (3-7)
|
5 (4-8)
4 (3-6
|
ARCI-MGB
Plc/Plc1
Plc/SYN115 |
1 (0-2)
3 (0-6)
|
2 (0-3)
4 (0-8)
|
1 (1-2)
2 (0-8)
|
1 (0-2)
2 (1-8)
|
ARCI-BG
Plc/Plc1
Plc/SYN115 |
4 (3-5)
5 (4-6)
|
4 (3-5)
6 (4-8)
|
4 (3-5)
5 (4-7)
|
4 (3-4)
5 (4-7)
|
ARCI-LSD
Plc/Plc1
Plc/SYN115 |
3 (2-4)
2.8 (2-3)
|
3.1 (3-4)
3 (2-4) |
4 (3-4)
3.3 (3-4)
|
4 (4-4)
3 (3-5)
|
* VAS “any effect”
Plc/Plc1
Plc/SYN115 |
2 (0-4)
4 (1-21)
|
2 (0-8)
6 (0-20)
|
2 (0-6)
10 (7-32)
|
7 (2-15)
15 (10-95)
|
*, ** VAS “good effects”
Plc/Plc1
Plc/SYN115 |
1 (0-5)
5 (2-23)
|
4 (2-13)
13 (2-30)
|
4 (0-10)
11 (7-34)
|
5 (3-19)
88 (16-107)
|
* VAS “bad effects”
Plc/Plc1
Plc/SYN115 |
0 (0-3)
4 (0-7)
|
3 (0-3)
0 (0-6)
|
0 (0-3)
8 (0-11)
|
3 (0-6)
12 (6-63)
|
** VAS “like effect”
Plc/Plc1
Plc/SYN115 |
1 (0-3)
6 (2-63)
|
4 (0-8)
11 (5-69)
|
5 (1-11)
12 (5-61)
|
5 (0-6)
77 (13-92)
|
VAS “friendly”
Plc/Plc1
Plc/SYN115 |
109 (0-114)
128 (5-158)
|
110 (4-122)
56 (0-171)
|
112 (0-125)
22 (6-128)
|
96 (7-118)
119 (47-171)
|
* VAS “confused”
Plc/Plc1
Plc/SYN115 |
1 (0-3)
4 (0-8)
|
4 (0-5)
3 (1-5)
|
3 (0-3)
8 (3-23)
|
4 (2-11)
7 (4-20)
|
VAS “able to concentrate”
Plc/Plc1
Plc/SYN115 |
128 (118-151)
175 (134-209)
|
114 (114-151)
134 (100-145)
|
114 (55-118)
123 (114-188)
|
114 (94-134)
150 (118-194)
|
** VAS “excited”
Plc/Plc1
Plc/SYN115 |
3 (0-13)
109 (7-115)
|
5 (4-55)
55 (5-122)
|
4 (0-6)
57 (25-119)
|
7 (5-114)
108 (23-119)
|
** VAS “alert”
Plc/Plc1
Plc/SYN115 |
114 (91-117)
137 (106-158)
|
105 (18-112)
125 (112-156)
|
59 (2-119)
156 (114-188)
|
79 (31-119)
139 (111-170)
|
VAS “relaxed”
Plc/Plc1
Plc/SYN115 |
114 (102-131)
136 (115-159)
|
108 (26-151)
123 (108-176)
|
113 (9-133)
130 (114-176)
|
79 (21-184)
122 (110-165)
|
